190 related articles for article (PubMed ID: 8534690)
1. Frequency of various types of peritoneal catheter infections and therapeutic outcome of treatment.
Gucek A; Benedik M; Zakelj B; Stanisavljevic D; Lindic J; Hergouth V; Bren AF
Adv Perit Dial; 1995; 11():149-51. PubMed ID: 8534690
[TBL] [Abstract][Full Text] [Related]
2. Persistent exit-site/tunnel infection and subcutaneous cuff removal in PD patients.
Suh H; Wadhwa NK; Cabralda T; Bonanno J; Wasiluk A; Sorrento J
Adv Perit Dial; 1997; 13():233-6. PubMed ID: 9360689
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous cuff removal in persistent exit-site/tunnel infections in peritoneal dialysis.
Suh H; Wadhwa NK; Cabralda T
Adv Perit Dial; 1995; 11():157-9. PubMed ID: 8534693
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
5. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients.
Wadhwa NK; Cabralda T; Suh H; Kvilekval K; Mason R
Adv Perit Dial; 1992; 8():325-7. PubMed ID: 1361816
[TBL] [Abstract][Full Text] [Related]
6. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
Cho KH; DO JY; Park JW; Yoon KW
Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
[TBL] [Abstract][Full Text] [Related]
7. How to record peritoneal catheter infections.
Gucek A; Stanisavljevic D; Benedik M; Premru V
Adv Perit Dial; 1998; 14():145-8. PubMed ID: 10649713
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience.
Szabo T; Siccion Z; Izatt S; Vas SI; Bargman J; Oreopoulos DG
Adv Perit Dial; 1999; 15():209-12. PubMed ID: 10682104
[TBL] [Abstract][Full Text] [Related]
9. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.
Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A
Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of exit-site infections due to Xanthomonas in CAPD patients: a comparison with Pseudomonas infection.
Dapena F; Selgas R; Garcia-Perea A; Del Peso G; Bajo MA; Fernandez Reyes MJ; Jimenez C; Sánchez C; Muñoz I; De Alvaro F
Nephrol Dial Transplant; 1994; 9(12):1774-7. PubMed ID: 7708263
[TBL] [Abstract][Full Text] [Related]
12. A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.
Luvira V; Satirapoj B; Supasyndh O; Chaiprasert A; Ruangkanchanasetr P; Nata N; Kanjanakul I; Supaporn T; Choovichian P; Bijaphala S; Luvira U; Phiboonbanakit D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S30-6. PubMed ID: 22043564
[TBL] [Abstract][Full Text] [Related]
13. Exit site infections: systematic microbiologic and quality control are needed.
Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.
Lui SL; Li FK; Lo CY; Lo WK
Adv Perit Dial; 2000; 16():195-7. PubMed ID: 11045292
[TBL] [Abstract][Full Text] [Related]
15. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
16. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
17. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).
Bernardini J; Holley JL; Johnston JR; Perlmutter JA; Piraino B
Clin Nephrol; 1991 Jul; 36(1):29-34. PubMed ID: 1889148
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
19. [Peritoneal dialysis: peritonitis and catheter infections].
Bergeron E; Denis R; Cartier P
Ann Chir; 1996; 50(8):606-12. PubMed ID: 9035432
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis.
Kleinpeter MA; Krane NK
Adv Perit Dial; 2001; 17():172-5. PubMed ID: 11510269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
